CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.72B, above the global median of $1.15B
- FinancialsAltman Z-Score 7.72: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.57%Above 5Y avg (0.44%)
Annual Rate
CNY 0.28Paid annual
Payout Ratio
29.5%Sustainable
Last Ex-Dividend
Jun 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
11.58BCNY1.72B · vs all stocks (USD)
Trailing P/E
55.08xRevenue (TTM)
2.11BCNY314.00M · vs all stocks (USD)
Profit Margin
9.96%Beta
0.5170xvs all stocks
52-Week Change
7.72%vs all stocks
Market Capitalization
11.58BCNY1.72B · vs all stocks (USD)
Enterprise Value
10.85BCNY1.61B · vs all stocks (USD)
Trailing P/E
55.08xForward P/E
41.86xPrice to Sales (TTM)
5.79xPrice to Book (MRQ)
2.67xEnterprise to Revenue
5.13xEnterprise to EBITDA
30.27xGross Margin
32.14%Profit Margin
9.96%Operating Margin
9.16%Return on Assets (TTM)
2.49%Return on Equity (TTM)
5.14%Revenue (TTM)
2.11BCNY314.00M · vs all stocks (USD)
Revenue per Share (TTM)
9.45CNYUpdated Aug 20, 2026Quarterly Revenue Growth
18.70%Gross Profit (TTM)
650.49MCNY96.61M · vs all stocks (USD)
EBITDA (TTM)
283.91MCNY42.17M · vs all stocks (USD)
Net Income (TTM)
210.68MCNY31.29M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
37.70%Operating Cash Flow (TTM)
392.80MCNY58.34M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
104.87MCNY15.58M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2800CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.57%vs all stocks
5-Year Average Dividend Yield
0.44%vs all stocks
Payout Ratio
29.47%Revenue
1.97BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.37BCNYFY2025 · Dec 31, 2025Gross Profit
608.45MCNYFY2025 · Dec 31, 2025Operating Income
254.62MCNY37.82M · vs all stocks (USD)
Pre-tax Income
207.61MCNYFY2025 · Dec 31, 2025Income Tax Expense
23.87MCNYFY2025 · Dec 31, 2025Net Income
183.74MCNYFY2025 · Dec 31, 2025EBIT
241.83MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
430.17MCNYFY2025 · Dec 31, 2025Research & Development
108.72MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
64.91MCNYFY2025 · Dec 31, 2025Other Operating Expenses
24.69MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.85MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
34.22MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.8800CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.8800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
208.79MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
208.79MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
183.74MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
534.61MCNYFY2025 · Dec 31, 2025Free Cash Flow
397.75MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
532.74MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
183.74MCNYFY2025 · Dec 31, 2025Other Non-cash Items
42.65MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
162.08MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
146.13MCNYFY2025 · Dec 31, 2025Capital Expenditures
-136.86MCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.01BCNYFY2025 · Dec 31, 2025Sale of Investments
3.97BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-176.80MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
100.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-275.01MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-65.75MCNYFY2025 · Dec 31, 2025Other Financing Charges
-1.71MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-242.46MCNYFY2025 · Dec 31, 2025Shares Outstanding
233.81MSharesUpdated Aug 20, 2026Float Shares
180.98MSharesUpdated Aug 20, 2026% Held by Insiders
22.58%vs all stocks
% Held by Institutions
4.27%vs all stocks
Total Cash (MRQ)
1.73BCNY256.76M · vs all stocks (USD)
Total Cash per Share (MRQ)
7.42CNYUpdated Aug 20, 2026Total Debt (MRQ)
121.85MCNY18.10M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0267xCurrent Ratio (MRQ)
3.94xBook Value per Share (MRQ)
19.60CNYUpdated Aug 20, 2026Total Assets
7.34BCNY1.09B · vs all stocks (USD)
Total Current Assets
2.68BCNYFY2025 · Dec 31, 2025Total Liabilities
1.04BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.66BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
417.91MCNYFY2025 · Dec 31, 2025Total Current Liabilities
621.82MCNYFY2025 · Dec 31, 2025Cash
383.54MCNYFY2025 · Dec 31, 2025Cash Equivalents
149.20MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
532.74MCNYFY2025 · Dec 31, 2025Other Short-term Investments
735.57MCNYFY2025 · Dec 31, 2025Accounts Receivable
381.41MCNYFY2025 · Dec 31, 2025Inventory
655.24MCNYFY2025 · Dec 31, 2025Accounts Payable
312.75MCNYFY2025 · Dec 31, 2025Short-term Debt
104.81MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.80MCNYFY2025 · Dec 31, 2025Long-term Debt
7.87MCNYFY2025 · Dec 31, 2025Common Stock (Book)
233.81MCNYFY2025 · Dec 31, 2025Retained Earnings
1.71BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
6.30BCNY935.70M · vs all stocks (USD)
Treasury Stock
30.04MCNYFY2025 · Dec 31, 202552-Week Low
30.90CNYUpdated Aug 20, 202652-Week High
56.71CNYUpdated Aug 20, 202652-Week Change
7.72%vs all stocks
Beta
0.5170xvs all stocks
50-Day MA
38.49CNYUpdated Aug 20, 2026200-Day MA
38.85CNYUpdated Aug 20, 2026Avg 10-Day Volume
34.46MSharesUpdated Aug 20, 2026Avg 30-Day Volume
24.00MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.9500CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 7.72: safe zoneNotable
Altman Z-Score: 7.72
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.72B, above the global median of $1.15BNotable
Market cap (USD): 1,719,238,031.651Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
MapLight Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
4DMedical Limited
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Inventisbio Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tibet Cheezheng Tibetan Medicine Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Taysha Gene Therapies Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Nolato AB
Tier 1ProductionApproval-Gated PipelineRule
Butterfly Network Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Alivus Life Sciences Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhejiang Conba Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jubilant Pharmova Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Nazara Technologies Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Nexxen International Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Biomarin Pharmaceutical Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities